474 results on '"Jansen, Tim L."'
Search Results
2. Discovery of calcite as a new pro-inflammatory calcium-containing crystal in human osteoarthritic synovial fluid
3. Test characteristics of Raman spectroscopy integrated with polarized light microscopy for the diagnosis of acute gouty arthritis
4. Lipid Crystals
5. Erosive Hand OsteoArthritis (EHOA): analysis of consecutive patients presenting with EHOA in a hospital-based rheumatology practice and its implications for an upcoming interventional study
6. Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout
7. Diagnostic Accuracy of Raman Spectroscopy Integrated With Polarized Light Microscopy for Calcium Pyrophosphate–Associated Arthritis.
8. The diagnostic accuracy of Raman spectroscopy integrated with polarized light microscopy for calcium pyrophosphate associated arthritis
9. Calcium carbonates are novel positive birefringent crystals in synovial fluid
10. Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis
11. Hughes-Stovin syndrome (HSS): current status and future perspectives
12. Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction
13. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial
14. The Prevalence of Titanium Dioxide Particles in Synovial Fluid Samples Drops after European Union Ban
15. Lessons and pitfalls from the 2020 Gout Clinical Practice Guideline presented in Atlanta at the ACR 2019
16. Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis
17. Lessons to be learned from real life data from 98 gout patients using benzbromarone
18. Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis
19. Reassessing the Safety Profile of Lesinurad in Combination with Xanthine Oxidase Inhibitor Therapy
20. International position paper on the appropriate use of uricosurics with the introduction of lesinurad
21. Real-life results of urate-driven pharmacotherapy with three urate lowering drugs in gout: allopurinol, febuxostat and benzbromarone
22. The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease
23. Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
24. Gout lessons from 2018: CARES, a direct comparison of febuxostat vs allopurinol, and CANTOS, IL1 blocker for cardiovascular risk minimisation
25. Vasodilator function worsens after cessation of tumour necrosis factor inhibitor therapy in patients with rheumatoid arthritis only if a flare occurs
26. Clinical image
27. Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment
28. Rational pharmacotherapy (RPT) in goutology: Define the serum uric acid target & treat-to-target patient cohort and review on urate lowering therapy (ULT) applying synthetic drugs
29. Pharmacothérapie rationnelle (PTR) de la goutte : utiliser la méthode du « Treat-to-Target » et bien définir l’uricémie finale visée
30. The American College of Physicians and the 2017 guideline for the management of acute and recurrent gout: treat to avoiding symptoms versus treat to target
31. Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients
32. Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey
33. Clinical image: synovitis of the metacarpophalangeal joints
34. Calcium carbonates are novel positive birefringent crystals in synovial fluid
35. What is the Place for Uricosuric Agents in Gout Management?
36. Association of Gout Polygenic Risk Score with Age at Disease Onset and Tophaceous Disease in European and Polynesian Men with Gout
37. Raman hyperspectral imaging detects novel and combinations of crystals in synovial fluids of patients with a swollen joint
38. Discrepancies in how the impact of gout is assessed in outcomes research compared to how health professionals view the impact of gout, using the lens of the International Classification of Functioning, Health and Disability (ICF)
39. Limited value for ultrasonography in predicting flare in rheumatoid arthritis patients with low disease activity stopping TNF inhibitors
40. Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard
41. Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout.
42. Clinical Images: Detection of titanium dioxide particles by Raman spectroscopy in synovial fluid from a swollen ankle
43. Clinical presentation of gout
44. Additional file 1 of Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout
45. Emerging and New Treatment Options for Knee Osteoarthritis
46. New gout test: enhanced ex vivo cytokine production from PBMCS in common gout patients and a gout patient with Kearns-Sayre syndrome
47. Valuable verities on vitamin D
48. Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra
49. Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases
50. Performance of classification criteria for gout in early and established disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.